Sign in Subscribe
Anti-obesity agents

NHS Wales Pauses Rollout of Weight-Loss Drugs due to Capacity Concerns

Strategic Insights

— 1 min read

NHS Wales has announced it will continue to restrict prescriptions of new weight-loss drugs due to concerns over the service's capacity to handle a surge in demand. The decision affects around 186,000 people eligible for tirzepatide, which has been approved for managing obesity by the National Institute for Health and Care Excellence (NICE). To address the issue, a new clinical pathway is being developed to increase capacity, and an interim rule has been implemented, allowing prescriptions only for specialist weight management services. Those already receiving the drugs on the NHS will be exempt from the new rule.

Key Takeaways:

  • The Welsh NHS has paused the rollout of weight-loss drugs due to concerns over its capacity to meet demand.
  • Approximately 186,000 people in Wales are eligible for tirzepatide (Mounjaro) for managing obesity.
  • An interim rule has been introduced, requiring prescriptions to be made by specialist weight management services.
  • Existing patients receiving the drugs on the NHS will be exempt from the new rule.
  • The new clinical pathway aims to develop a model for treating obesity as a chronic, recurring condition.
  • The implementation period for tirzepatide has been extended from 2 months to up to 12 years due to NICE's exemption.
  • Specialist weight management services will be responsible for prescribing semaglutide (Wegovy) and liraglutide (Saxenda).
  • A small number of high-need patients, such as those with cancer or in fertility services, will be exceptions to the new rule.

Statistics:

  • 186,000 people in Wales are eligible for tirzepatide for managing obesity.
  • Tirzepatide has been approved by NICE for managing obesity.
  • The implementation period for tirzepatide has been extended from 2 to 12 years.
  • The number of people using semaglutide and liraglutide is not specified in the source material.

Sources:

  • "ICNN Senedd reporter Chris Haines."
  • "National Institute for Health and Care Excellence (NICE)."
  • Welsh Government officials.

Read more